IL19 and breast cancer: (HR ​= ​1.57, log-rank P = 0.00013) (Fig. 7B). Thus, higher levels of IL-19 and IL20RA in BC patients lead to worse prognosis as related to the patients having lower levels of IL-19 and IL20RA.